The Supreme Court said on Tuesday that it would hear an appeal by Merck & Co. of a ruling that reinstated a securities fraud lawsuit involving the company’s disclosures to investors about its withdrawn Vioxx pain drug.
*For more on this story,
read the full Reuters article.
